Bombinin-Like Peptide BLP-1
CAS No. 138220-00-5
Bombinin-Like Peptide BLP-1 ( )
Catalog No. M30452 CAS No. 138220-00-5
Bombinin-Like Peptide (BLP-1) is an antimicrobial peptide from Bombina species.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 259 | Get Quote |
|
10MG | 409 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameBombinin-Like Peptide BLP-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionBombinin-Like Peptide (BLP-1) is an antimicrobial peptide from Bombina species.
-
DescriptionBombinin-Like Peptide (BLP-1) is an antimicrobial peptide from Bombina species.(In Vitro):Bombinin-like peptides, BLP-1, 2, 3 share considerable, but not complete, homology with bombinin, an antimicrobial, hemolytic peptide first isolated from the skin of Bombina uariegata. The BLPs have been assayed for antibiotic and hemolytic activity and found to be more potent than magainin 2 (a related antimicrobial peptide from Xenopus laeuis) in their ability to kill bacteria.
-
Synonyms
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number138220-00-5
-
Formula Weight2581
-
Molecular FormulaC115H194N34O33
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Gibson BW, et al. Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis. J Biol Chem. 1991 Dec 5;266(34):23103-11.
molnova catalog
related products
-
VXc-486
VXc-486 (VXc486) is a novel inhibitor of gyrase B, potently inhibits multiple drug-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis in vitro.
-
Taniborbactam
Taniborbactam is a novel beta-lactamase inhibitor for the treatment of bacterial infections.
-
Gatifloxacin hydroch...
A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.